170 related articles for article (PubMed ID: 33285664)
1. Intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar in patients with pelvic locoregional recurrence of cervical cancer: Results from a hospital in the Qinghai-Tibet Plateau.
Zhang K; Wang H; Wang Z; Li F; Cui Y; Ma S; Chen R; Wang Y; Guo S; Wei Y
Medicine (Baltimore); 2020 Dec; 99(49):e21966. PubMed ID: 33285664
[TBL] [Abstract][Full Text] [Related]
2. Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Chen Z; Long X; Pang Q; Peng L; Li X; Gu J; Deng S; Xing L
Oncol Res; 2022 Jan; 28(9):929-944. PubMed ID: 34544526
[TBL] [Abstract][Full Text] [Related]
3. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
4. A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update.
Li Y; Tian Y; Jin F; Wu W; Long J; Ouyang J; Zhou Y
Curr Probl Cancer; 2020 Feb; 44(1):100492. PubMed ID: 32035692
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S; Isohashi F; Yokoi T; Takemura M; Yoshino K; Shiki Y; Ito K; Enomoto T; Ogawa K; Kimura T
Gynecol Oncol; 2016 May; 141(2):240-246. PubMed ID: 26883141
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors.
Shu P; Shen Y; Zhao Y; Xu F; Qiu M; Li Q; Gou H; Cao D; Yang Y; Liu J; Yi C; Liao Z; Luo D; Bi F; Wang X; Li Z
Med Oncol; 2015 Nov; 32(11):247. PubMed ID: 26433959
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma.
Guan Y; Li A; Xiao W; Liu S; Chen B; Lu T; Zhao C; Han F
Oncotarget; 2015 Oct; 6(32):33926-34. PubMed ID: 26418895
[TBL] [Abstract][Full Text] [Related]
9. HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer.
Zhai Y; Ma H; Hui Z; Zhao L; Li D; Liang J; Wang X; Xu L; Chen B; Tang Y; Wu R; Xu Y; Pang Q; Chen M; Wang L
Radiother Oncol; 2019 Feb; 131():27-34. PubMed ID: 30773184
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L; Zhang YW; Hu CS; Guo Y
Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
[TBL] [Abstract][Full Text] [Related]
12. IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study.
Lv T; Wang Y; Ou D; Liu P; Qin S; Liu L; Lou P; Wang X
Invest New Drugs; 2019 Apr; 37(2):352-359. PubMed ID: 30617703
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
Rose PG; Sill MW; McMeekin DS; Ahmed A; Salani R; Yamada SD; Wolfson AH; Fusco N; Fracasso PM
Gynecol Oncol; 2012 Apr; 125(1):158-62. PubMed ID: 22198338
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.
Sun W; Wang T; Shi F; Wang J; Wang J; Hui B; Zhang Y; Lu J; Chen H; Liu Z
BMC Cancer; 2015 May; 15():353. PubMed ID: 25935645
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial.
Wang X; Shen Y; Zhao Y; Li Z; Gou H; Cao D; Yang Y; Qiu M; Li Q; Liu J; Yi C; Liao Z; Luo D; Xu F; Bi F
Eur J Surg Oncol; 2015 Aug; 41(8):1082-8. PubMed ID: 26033265
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
Yin Y; Zhou Z; Li Z; Shen M; Qin Y; Yang C; Wang R; Kang M
Radiat Oncol; 2022 Jul; 17(1):135. PubMed ID: 35906636
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer.
Zhao N; Li Y; Chen X; Ma J; Luo W; Li Y
J Cancer Res Clin Oncol; 2024 May; 150(5):233. PubMed ID: 38709400
[TBL] [Abstract][Full Text] [Related]
20. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
